Class I MHC mediated antigen processing & presentation
基因
试剂
文献样例
产品评述样例
ANAPC1
anaphase promoting complex subunit 1
总数:1
Meningiomas exhibit loss of heterozygosity of the APC gene. 2008 至该文献
为了研究脑膜瘤中腺瘤样肠息肉病基因的杂合子丢失,采用了Calbiochem的单克隆鼠抗人APC-1抗体(1:50)进行免疫组织化学试验。
ANAPC7
anaphase promoting complex subunit 7
总数:1
Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships. 2005 至该文献
ARIH2
ariadne RBR E3 ubiquitin protein ligase 2
ASB1
ankyrin repeat and SOCS box containing 1
ASB10
ankyrin repeat and SOCS box containing 10
ASB11
ankyrin repeat and SOCS box containing 11
ASB12
ankyrin repeat and SOCS box containing 12
ASB13
ankyrin repeat and SOCS box containing 13
ASB14
ankyrin repeat and SOCS box containing 14
ASB15
ankyrin repeat and SOCS box containing 15
ASB16
ankyrin repeat and SOCS box containing 16
ASB17
ankyrin repeat and SOCS box containing 17
ASB18
ankyrin repeat and SOCS box containing 18
ASB2
ankyrin repeat and SOCS box containing 2
ASB4
ankyrin repeat and SOCS box containing 4
ASB5
ankyrin repeat and SOCS box containing 5
ASB6
ankyrin repeat and SOCS box containing 6
ASB7
ankyrin repeat and SOCS box containing 7
ASB8
ankyrin repeat and SOCS box containing 8
ATG7
autophagy related 7
总数:9
Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress. 2012 至该文献
为了研究p53依赖的细胞增殖和存活能够被atg7调控,采用了Millipore的抗Atg7抗体进行蛋白印迹和ChIP实验。 更多
B2M
beta-2-microglobulin
总数:5
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. 2008 至该文献
为了研究特定人群的肿瘤浸润淋巴细胞在诊断原发性黑色素瘤切片检查中的出现可以鉴定为临床阶段Ⅱ期黑色素瘤病人,采用了Dako的B2m的抗体进行了免疫组化实验。 更多
Bip
heat shock protein family A (Hsp70) member 5
总数:47
RanBP2/Nup358 potentiates the translation of a subset of mRNAs encoding secretory proteins. 2013 至该文献
为了研究RanBP2/Nup358促使的分泌蛋白的翻译,采用了abcam公司的抗GRP78/BiP 兔多克隆抗体(1:25) 进行免疫印迹实验 更多
BTRC
beta-transducin repeat containing E3 ubiquitin protein ligase
总数:2
Regulated degradation of FANCM in the Fanconi anemia pathway during mitosis. 2009 至该文献
为了研究FANCM在有丝分裂过程中的降解机制,使用了Zymed Laboratories的小鼠抗β-TRCP抗体来进行免疫印迹分析。 更多
钙联接蛋白 (calnexin)
总数:75
A Bacteriophage tailspike domain promotes self-cleavage of a human membrane-bound transcription factor, the myelin regulatory factor MYRF. 2013 至该文献
为了研究MYRF的自剪切机制,Santa Cruz Biotechnology的兔抗钙联接蛋白抗体和羊抗钙联接蛋白抗体被用于进行蛋白质免疫印迹和免疫细胞化学实验。 更多
钙网蛋白 (calreticulin)
总数:39
Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. 2010 至该文献
为了研究高效肝炎C病毒颗粒的形成条件,采用了Stressgen公司的抗calreticulin抗体进行蛋白免疫印迹实验及免疫细胞化学实验。 更多
CBLB
Cbl proto-oncogene B
总数:3
LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. 2007 至该文献
CD36
CD36 molecule
总数:16
A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. 2010 至该文献
为了说明在TRl信号通路的介导下间质干细胞能被极化成两种截然不同的表型,采用了eBiosciences公司的抗CD36抗体进行流式细胞术和免疫细胞化学实验。 更多
CD64
Fc fragment of IgG receptor Ia
总数:15
PPAR? controls Dectin-1 expression required for host antifungal defense against Candida albicans. 2010 至该文献
为了研究PPARgamm在调控dectin-1的表达和宿主抗真菌防御中的作用,采用了Serotec公司的抗F4/80抗体产品,进行了流式细胞分析实验。 更多
CDC20
cell division cycle 20
总数:6
Critical role of Pcid2 in B cell survival through the regulation of MAD2 expression. 2010 至该文献
为了研究Pcid2通过调控MAD2表达在B细胞生存中发挥的决定性作用,采用了Santa Cruz Biotechnology公司的抗p55CDC单克隆抗体进行免疫印迹试验。 更多
CDC27
cell division cycle 27
总数:8
Host factors required for modulation of phagosome biogenesis and proliferation of Francisella tularensis within the cytosol. 2010 至该文献
为研究细胞内F. tularensis细菌的吞噬体发生和增值的调节,采用了Abcam公司的抗CDC27抗体进行蛋白质印迹试验。 更多
CDC34
cell division cycle 34
总数:2
Novel control of S phase of the cell cycle by ubiquitin-conjugating enzyme H7. 2009 至该文献
为研究UbcH7在细胞周期的s期时所起的调控作用,使用了Santa Cruz公司的抗Ubc3抗体来进行免疫组化分析。 更多
CHIP
STIP1 homology and U-box containing protein 1
总数:11
In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis. 2009 至该文献
为了说明增强CHIP活性可以有助于治疗SCA3或者其他的polyQ疾病,使用了abcam公司的兔抗CHIP抗体进行蛋白印迹实验。 更多
CTSS
cathepsin S
总数:4
T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice. 2009 至该文献
使用Abcam羊多克隆抗组织蛋白酶S抗体来阻断和培育蛋白印记,来证明T细胞激活会阻止动脉粥样斑块中胶原的成熟。 更多
CTSV
cathepsin V
总数:2
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification. 2006 至该文献
Cul1
cullin 1
总数:12
Mediator acts upstream of the transcriptional activator Gal4. 2012 至该文献
为了研究Mediator复合物是如何起始Gal4基因转录的,采用了Abcam公司的抗Cul1抗体进行了免疫共沉淀实验。 更多
Cul2
cullin 2
总数:10
An interaction network of the mammalian COP9 signalosome identifies Dda1 as a core subunit of multiple Cul4-based E3 ligases. 2009 至该文献
为了考察E3 ligases中CRL家族的新成员和阐明CRL与CSN相互作用复合物中的新的连接分子,用Rockland Immunochemicals 公司的anti-Cul2抗体进行了免疫共沉淀实验。 更多
CUL3
cullin 3
总数:4
Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. 2010 至该文献
为了研究类鼻疽杆菌的CHBP蛋白作为真核细胞的泛素化途径的强抑制剂的功能,使用了Santa Cruz Biotechnology公司的抗Cul3抗体来进行免疫印迹分析。 更多
CYBA
cytochrome b-245 alpha chain
总数:4
The association of vascular endothelial growth factor receptor-1 with the risk of cancer progression following radical prostatectomy. 2008 至该文献
为研究C反应蛋白在抑制人巨噬泡沫细胞胆固醇外流中的分子机制,采用Novus Biologicals公司鼠抗- p22-phox单克隆抗体进行Western免疫印迹实验。 更多
CYBB
cytochrome b-245 beta chain
总数:7
IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase. 2009 至该文献
为了研究IL-6对前脑GABAergic中间神经元退化中的作用以及对老年老鼠的认知损伤的影响,使用了BD Transduction公司的抗Nox2单克隆抗体来进行免疫细胞化学实验。 更多
DET1
DET1 partner of COP1 E3 ubiquitin ligase
DZIP3
DAZ interacting zinc finger protein 3
ERAP1
endoplasmic reticulum aminopeptidase 1
ERp57
protein disulfide isomerase family A member 3
总数:4
Endoplasmic reticulum chaperones stabilize nicotinic receptor subunits and regulate receptor assembly. 2007 至该文献
FBXW7
F-box and WD repeat domain containing 7
总数:1
Cell-cell contact globally activates microRNA biogenesis. 2009 至该文献
为了研究细胞间接触与microRNA合成之间的联系,使用了Upstate公司的抗Ago家族蛋白抗体来进行蛋白印迹分析。
FBXW8
F-box and WD repeat domain containing 8
FZR1
fizzy and cell division cycle 20 related 1
总数:2
Regulation of Skp2-p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis. 2008 至该文献
E-cadherin基因(Cdh1)抗体(Calbiochem公司生产)可用于免疫印迹实验,来研究Cdh1/APC在肿瘤发生过程中的作用。 更多
HECTD3
HECT domain E3 ubiquitin protein ligase 3
HERC2
HECT and RLD domain containing E3 ubiquitin protein ligase 2
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
HLA E (HLA E)
major histocompatibility complex, class I, E
总数:12
ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. 2012 至该文献
为了研究ESCRT-III调控Aurora B介导的细胞脱落,采用了Serotec的FITC标记的抗MHC-I抗体进行流式细胞分选实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-F (HLA-F)
major histocompatibility complex, class I, F
总数:1
Progressive myopathy and defects in the maintenance of myotendinous junctions in mice that lack talin 1 in skeletal muscle. 2008 至该文献
为了研究talin 1在骨骼肌发育和功能中的作用,采用了Sigma的鼠抗MHCf单抗,进行免疫组化实验
HUWE1
HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1
整合素αⅤ (integrin alpha v)
integrin subunit alpha V
总数:24
TGFBI expression is associated with a better response to chemotherapy in NSCLC. 2010 至该文献
为了确定整合素αvβ3是否影响TGFBI介导的NSCLC细胞对化学疗法的敏感性,采用Chemicon Interational的抗整合素αvβ3单抗进行流式细胞术实验。 更多
ITCH
itchy E3 ubiquitin protein ligase
总数:3
Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradation. 2009 至该文献
为了阐明体内调节ΔNp63蛋白稳定性的机制,采用了BD Biosciences的Itch抗体进行免疫沉淀和免疫印迹试验。 更多
ITGB5
integrin subunit beta 5
总数:9
Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. 2008 至该文献
为了阐明beta诱导的转化生长因子(βig-h3/TGFBI)能够在体内增强结肠癌细胞的攻击性并改变其代谢特征,采用了Chemicon, Inc的αvβ5 抗体进行免疫印迹试验。 更多
KEAP1
kelch like ECH associated protein 1
总数:4
Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. 2009 至该文献
为了说明铁硫蛋白合成受损影响了遗传性共济失调中的氧化应激反应,使用了Santa Cruz Biotechnology公司的Keap1抗体来进行免疫组化实验。 更多
LRSAM1
leucine rich repeat and sterile alpha motif containing 1
MKRN1
makorin ring finger protein 1
总数:1
Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. 2009 至该文献
为研究高密度SNP基础的基因型排列分析检测小儿低级星形细胞瘤7q34重复区发现的新型BRAF融合基因,采用了Abcam公司的抗MKRN1抗体进行蛋白质印迹试验。
MRC1
mannose receptor C-type 1
总数:2
Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens. 2010 至该文献
为研究抗菌肽hLF1-11对人类单核细胞向巨噬细胞分化的影响,采用了BD Biosciences公司的抗CD206单克隆抗体进行流式细胞术试验。 更多
NCF4
neutrophil cytosolic factor 4
总数:2
A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis. 2006 至该文献
NEDD4
NEDD4 E3 ubiquitin protein ligase
总数:3
The inositol phosphatase MTMR4 is a novel target of the ubiquitin ligase Nedd4. 2009 至该文献
为了研究Nedd4在肌肉萎缩过程中所起的作用,使用了Upstate公司的抗Nedd4抗体来进行蛋白印迹分析。 更多
NPEPPS
aminopeptidase puromycin sensitive
总数:2
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. 2008 至该文献
oxytocinase
leucyl and cystinyl aminopeptidase
总数:4
Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1. 2009 至该文献
使用ABDSerotec的羊多克隆抗PLAP抗体(0300-1909)进行免疫印迹实验来来分析由顶端PPM的供给特异性引起的早期事件和肠上皮PPM传感的分子机制。 更多
p47phox
neutrophil cytosolic factor 1
总数:10
The association of vascular endothelial growth factor receptor-1 with the risk of cancer progression following radical prostatectomy. 2008 至该文献
为研究C反应蛋白在抑制人巨噬泡沫细胞胆固醇外流中的分子机制,采用Novus Biologicals公司抗- p47-phox抗体进行Western免疫印迹实验。 更多
p600
ubiquitin protein ligase E3 component n-recognin 4
p67phox
neutrophil cytosolic factor 2
总数:8
The association of vascular endothelial growth factor receptor-1 with the risk of cancer progression following radical prostatectomy. 2008 至该文献
为研究C反应蛋白在抑制人巨噬泡沫细胞胆固醇外流中的分子机制,采用Novus Biologicals公司鼠抗-p67-phox多克隆抗体(H00004688-B01)进行Western免疫印迹实验。 更多
PA200
proteasome activator subunit 4
总数:1
Transformation of the proteasome with age-related macular degeneration. 2007 至该文献
为了研究在年龄相关的斑点降解(AMD)疾病过程中蛋白酶体是如何变化的,采用了Affinity Bioreagents公司的蛋白酶体调节蛋白PA200抗体,进行了蛋白质印迹实验.
PJA1
praja ring finger ubiquitin ligase 1
PJA2
praja ring finger ubiquitin ligase 2
PLZF
zinc finger and BTB domain containing 16
总数:2
Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. 2005 至该文献
PSMA1
proteasome 20S subunit alpha 1
总数:9
Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. 2008 至该文献
PSMA3
proteasome 20S subunit alpha 3
总数:3
Two histone marks establish the inner centromere and chromosome bi-orientation. 2010 至该文献
为了研究内着丝粒是如何建立的和CPC复合物是如何靶向到此位点的机制,使用了Santa Cruz Biotechnology公司的抗Psc3抗体来进行染色质免疫沉淀实验。 更多
PSMA4
proteasome 20S subunit alpha 4
总数:3
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. 2010 至该文献
为了研究免疫蛋白酶体在多发性硬化发病机制的作用,采用Affinity-Biomol International小鼠抗人的20S proteasome subunit alpha4单克隆抗体进行免疫组织化学试验。 更多
PSMA7
proteasome 20S subunit alpha 7
总数:4
Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. 2009 至该文献
为了在内质网相关蛋白的降解途径(ERAD)中鉴定一种新的erasin-ubiquilin-p97/VCP复合体以及其功能,使用了Enzo Life Sciences公司的抗体alpha7来进行免疫印迹分析。 更多
PSMB1
proteasome 20S subunit beta 1
总数:2
Transformation of the proteasome with age-related macular degeneration. 2007 至该文献
为了研究在年龄相关的斑点降解(AMD)疾病过程中蛋白酶体是如何变化的,采用了Affinity Bioreagents公司的蛋白酶体亚基β1抗体,进行了蛋白质印迹实验. 更多
PSMB5
proteasome 20S subunit beta 5
总数:1
Transformation of the proteasome with age-related macular degeneration. 2007 至该文献
为了研究在年龄相关的斑点降解(AMD)疾病过程中蛋白酶体是如何变化的,采用了Affinity Bioreagents公司的蛋白酶体亚基β5抗体,进行了蛋白质印迹实验.
PSMB8
proteasome 20S subunit beta 8
总数:3
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. 2010 至该文献
为了研究免疫蛋白酶体在多发性硬化发病机制的作用,采用Affinity-Biomol International抗LMP7抗体进行免疫组织化学试验。 更多
PSMB9
proteasome 20S subunit beta 9
总数:2
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. 2010 至该文献
为了研究免疫蛋白酶体在多发性硬化发病机制的作用,采用Affinity-Biomol International抗LMP2抗体进行免疫组织化学试验。 更多
PSMC4
proteasome 26S subunit, ATPase 4
总数:8
Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. 2010 至该文献
为了研究在帕金森疾病模型中雷怕霉素对神经元的保护作用,采用了Cell Signaling Technology的抗phospho-Ser235/236-S6抗体进行免疫细胞化学试验。 更多
PSMC6
proteasome 26S subunit, ATPase 6
总数:1
Physical and functional interactions of the lysophosphatidic acid receptors with PDZ domain-containing Rho guanine nucleotide exchange factors (RhoGEFs). 2005 至该文献
PSMD2
proteasome 26S subunit, non-ATPase 2
总数:1
HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome. 2010 至该文献
为了说明hHR23A介导的Vpr与蛋白酶体的互作在病毒复制过程中有重要作用,使用了Calbiochem公司的19S蛋白酶体S2亚基的兔多抗来进行免疫印记实验。
PSMD4
proteasome 26S subunit, non-ATPase 4
总数:3
HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome. 2010 至该文献
为了说明hHR23A介导的Vpr与蛋白酶体的互作在病毒复制过程中有重要作用,使用了Calbiochem公司的19S蛋白酶体S5a亚基的兔多抗来进行免疫印记实验。 更多
PSMD9
proteasome 26S subunit, non-ATPase 9
总数:13
ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer. 2012 至该文献
为了研究在管腔乳腺癌中雌激素敏感性以及抗雌激素抗性的获得,采用了Santa Cruz 的抗p27抗体进行了western blot实验。 更多
PSME1
proteasome activator subunit 1
总数:3
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. 2010 至该文献
为了研究免疫蛋白酶体在多发性硬化中的作用,采用Affinity-Biomol International兔抗PA28alpha多克隆抗体进行免疫组织化学试验。 更多
PSME2
proteasome activator subunit 2
总数:1
Chronic ethanol feeding affects proteasome-interacting proteins. 2009 至该文献
为了确认长期酒精喂养对蛋白酶体相互作用蛋白表达的影响,采用了BIOMOL公司的抗PA28β抗体进行免疫印迹法实验。
RBCK1
RANBP2-type and C3HC4-type zinc finger containing 1
RBX1
ring-box 1
总数:5
Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes. 2008 至该文献
RNF41
ring finger protein 41
总数:1
Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth. 2006 至该文献
为研究泛素连接酶Nrdp1在癌症进展中的表达及其作用,采用Bethyl公司生产的 FLRF/Nrdp1抗体用于免疫印迹实验。
RPS27A
ribosomal protein S27a
总数:5
Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. 2009 至该文献
为了在内质网相关蛋白的降解途径(ERAD)中鉴定一种新的erasin-ubiquilin-p97/VCP复合体以及其功能,使用了Santa Cruz Biotechnology公司的抗体ubiquitin来进行免疫印迹分析。 更多
SAR1B
secretion associated Ras related GTPase 1B
SEC13
SEC13 homolog, nuclear pore and COPII coat complex component
SEC23A
Sec23 homolog A, COPII coat complex component
总数:3
Rab1b interacts with GBF1 and modulates both ARF1 dynamics and COPI association. 2007 至该文献
SEC24A
SEC24 homolog A, COPII coat complex component
SEC24B
SEC24 homolog B, COPII coat complex component
SEC24C
SEC24 homolog C, COPII coat complex component
SEC24D
SEC24 homolog D, COPII coat complex component
SEC31A
SEC31 homolog A, COPII coat complex component
SEC61B
SEC61 translocon subunit beta
总数:1
Host ER-parasitophorous vacuole interaction provides a route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. 2009 至该文献
为了阐明病原刺激的内质网-纳虫空泡的相互作用有利于抗原进入MHCI途径和CD8+ T细胞,采用了Proteintech Group, Inc.的Sec61b抗体进行免疫荧光和免疫金标记试验。
SEC61G
SEC61 translocon subunit gamma
Skp1
S-phase kinase associated protein 1
总数:8
APC/C- and Mad2-mediated degradation of Cdc20 during spindle checkpoint activation. 2009 至该文献
Skp2
S-phase kinase associated protein 2
总数:17
Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy. 2009 至该文献
为了在K562细胞中研究CSN对细胞自噬有重要作用,采用Zymed的抗Skp2抗体以1:1000稀释进行蛋白印迹实验。 更多
SMURF1
SMAD specific E3 ubiquitin protein ligase 1
总数:3
Smad ubiquitination regulatory factor 2 promotes metastasis of breast cancer cells by enhancing migration and invasiveness. 2009 至该文献
为了研究Smurf2在促进乳腺癌转移中的功能,使用了Santa Cruz Biotechnology公司的抗Smurf1抗体来进行免疫印迹分析和免疫组化实验。 更多
SMURF2
SMAD specific E3 ubiquitin protein ligase 2
总数:3
Smad ubiquitination regulatory factor 2 promotes metastasis of breast cancer cells by enhancing migration and invasiveness. 2009 至该文献
为了研究Smurf2在促进乳腺癌转移中的功能,使用了Santa Cruz Biotechnology公司的抗Smurf2抗体来进行免疫印迹分析和免疫组化实验。 更多
SOCS3
suppressor of cytokine signaling 3
总数:10
Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. 2009 至该文献
为了研究已故捐献者DD)和活人捐献者(LD)肝脏移植在分子水平上的显著差异,采用了Santa Cruz Biotech公司的SOCS3抗体,进行了免疫组织化学实验。 更多
SPSB2
splA/ryanodine receptor domain and SOCS box containing 2
SPSB4
splA/ryanodine receptor domain and SOCS box containing 4
SSB 1 (SSB 1)
splA/ryanodine receptor domain and SOCS box containing 1
总数:1
A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling. 2011 至该文献
为了研究DNA损伤应答过程中RHINO对ATR活化的重要作用,采用Bethyl的抗SSB1抗体进行蛋白印迹和免疫沉淀实验。
TAP1
transporter 1, ATP binding cassette subfamily B member
ELOB
elongin B
总数:4
Association of SAP130/SF3b-3 with Cullin-RING ubiquitin ligase complexes and its regulation by the COP9 signalosome. 2008 至该文献
为了阐明SAP130蛋白可能将CRL介导的泛素化与基因表达相联系,采用了Santa Cruz公司的抗延伸蛋白B抗体,进行了免疫沉淀实验。 更多
TRIM32
tripartite motif containing 32
总数:2
Suppression of Sproutys has a therapeutic effect for a mouse model of ischemia by enhancing angiogenesis. 2009 至该文献
为了研究sproutys在调控小鼠血管生成和局部缺血中的作用,采用了Santa Cruz Biotechnology公司的抗VEGFR-2抗体产品,进行了免疫印迹实验。 更多
UBA1
ubiquitin like modifier activating enzyme 1
总数:4
Spatially and temporally specific expression in mouse hippocampus of Usp9x, a ubiquitin-specific protease involved in synaptic development. 2005 至该文献
Upstate Biotechnology的抗Ube1x单克隆抗体被用于免疫细胞化学实验,来研究Usp9x在突触可塑性中的作用。 更多
UBA3
ubiquitin like modifier activating enzyme 3
UBA5
ubiquitin like modifier activating enzyme 5
UBA6
ubiquitin like modifier activating enzyme 6
UBC
ubiquitin C
总数:7
The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity. 2014 至该文献
为了研究突触的可塑性,采用了Enzo Life Sciences的抗Ubiquitin的抗体进行了免疫印迹实验。 更多
UbcH7
ubiquitin conjugating enzyme E2 L3
总数:4
Novel control of S phase of the cell cycle by ubiquitin-conjugating enzyme H7. 2009 至该文献
为研究UbcH7在细胞周期的s期时所起的调控作用,使用了BD Biosciences公司的抗UbcH7抗体来进行免疫组化分析。 更多
UBE2B
ubiquitin conjugating enzyme E2 B
总数:1
Novel control of S phase of the cell cycle by ubiquitin-conjugating enzyme H7. 2009 至该文献
为研究UbcH7在细胞周期的s期时所起的调控作用,使用了Boston Biochem公司的抗Ubc2抗体来进行免疫组化分析。
UBE2C
ubiquitin conjugating enzyme E2 C
总数:3
Novel control of S phase of the cell cycle by ubiquitin-conjugating enzyme H7. 2009 至该文献
为研究UbcH7在细胞周期的s期时所起的调控作用,使用了Boston Biochem公司的抗UbcH10抗体来进行免疫组化分析。 更多
UBE2D1
ubiquitin conjugating enzyme E2 D1
总数:1
Mammalian DET1 regulates Cul4A activity and forms stable complexes with E2 ubiquitin-conjugating enzymes. 2007 至该文献
为了研究DET1在Cul4A活性调控上所起的作用,使用了Boston Biochem公司的抗UbcH5抗体来进行免疫沉淀分析。
UBE2D3
ubiquitin conjugating enzyme E2 D3
总数:1
Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. 2010 至该文献
为了研究A20抑制NF-kappaB信号途径的机制,使用了Abcam公司的抗UbcH5c抗体来进行蛋白印迹分析。
UBE2D4
ubiquitin conjugating enzyme E2 D4 (putative)
UBE2F
ubiquitin conjugating enzyme E2 F (putative)
UBE2G2
ubiquitin conjugating enzyme E2 G2
总数:1
Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation. 2008 至该文献
为了研究自噬是硫嘌呤甲基转移酶的同种异型酶 TPMT*3A降解的机制之一,采用了Abgent的抗UBE2G2抗体进行免疫印迹实验。
UBE2L6
ubiquitin conjugating enzyme E2 L6
总数:1
A phosphorylation-acetylation switch regulates STAT1 signaling. 2009 至该文献
为了研究磷酸化-乙酰化开关在调控STAT1信号通路中的作用,采用了Abgent 公司的UBCH8抗体产品,进行了免疫印迹实验。
UBE2N
ubiquitin conjugating enzyme E2 N
总数:3
A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling. 2011 至该文献
为了研究DNA损伤应答过程中RHINO对ATR活化的重要作用,采用Invitrogen的抗Ubc13抗体进行蛋白印迹实验。 更多
UBE3A
ubiquitin protein ligase E3A
总数:5
Novel control of S phase of the cell cycle by ubiquitin-conjugating enzyme H7. 2009 至该文献
为研究UbcH7在细胞周期的s期时所起的调控作用,使用了Affinity Bioreagents公司的抗E6-AP抗体来进行免疫组化分析。 更多
泛肽 (ubiquitin)
ubiquitin B
总数:34
BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers. 2009 至该文献
为了阐明BCL6和HB-EGF-CTF相互作用,并且这种相互作用可能会引起细胞周期蛋白D2在人胃癌细胞中表达,采用了Cell Signaling Technology公司的小鼠抗泛素单克隆抗体,进行了蛋白质印迹实验。 更多
UBR1
ubiquitin protein ligase E3 component n-recognin 1
UBR2
ubiquitin protein ligase E3 component n-recognin 2
VHL
von Hippel-Lindau tumor suppressor
总数:14
The HILDA complex coordinates a conditional switch in the 3'-untranslated region of the VEGFA mRNA. 2013 至该文献
为了研究HILDA复合物对VEGF-A表达的调控作用,GeneTex的抗VHL抗体被用于进行蛋白质免疫印迹和免疫沉淀实验。 更多
DCAF1
DDB1 and CUL4 associated factor 1
总数:3
Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R. 2010 至该文献
为了研究vpr在细胞周期G2期中拷贝数的变化,采用了abcam的抗vprbr抗体进行免疫印迹实验。 更多
WSB1
WD repeat and SOCS box containing 1
WWP1
WW domain containing E3 ubiquitin protein ligase 1
总数:1
Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. 2006 至该文献